Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Myriad Proteomics, CEO Thomas Ingolia Look for New Life in Drug Discovery Collaborations

Myriad Proteomics, CEO Thomas Ingolia Look for New Life in Drug Discovery Collaborations

Jul 04, 2003
Premium

Myriad Proteomics of Salt Lake City and its new CEO Thomas Ingolia have jumped on the drug discovery bandwagon — and are now riding it full speed. Armed with an array of new and established technologies, most notably a target pull-down approach known as chemiproteomics, Myriad has abandoned its quest to map the entire human proteome and now hopes to carve out a niche in the increasingly crowded field of collaborative target validation and discovery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Mix of Human and Monkey

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

Fetal Tissue Policy Changes Expected

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

Science Papers on Approach to Isolate DNA from Sediment, Algorithm to Construct Signaling Networks

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Sequencing the Zoo

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.

Apr
20
Featured Webinar

Analysis of a Wellness Cohort Identifies Markers of Metastatic Cancer Years Prior to Diagnosis

Sponsored by
Olink

This webinar will discuss a study that sought to identify early biomarkers for cancer by analyzing pre-diagnosis samples from seemingly healthy individuals who were later diagnosed with cancer.

Apr
23
Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

May
10
Featured Webinar

Predicting COVID-19 Severity: Leveraging the Host Immune Response to Identify High-Risk Patients and Improve Outcomes

Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
20
Featured Webinar

Using Spatial Transcriptomics to Understand the Molecular Mechanisms of Memory

Sponsored by
ACD

This webinar will present a research project that is using spatial transcriptomics to discern the molecular mechanisms underlying fear memory.  

What's Popular?

In Proteomics & Protein Research

  1. Proteome Sciences' TMTcalibrator Could Enable Deep Plasma Proteomic Analysis

    Premium

  2. ImmunoScape Closes $14M Funding Round

  3. Proteomic Study of SARS-CoV-2, SARS-CoV Infections Points to Potential Drug Targets

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.